Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-23

Clinical Trial Update: Does DHEA IVF Outcomes in Poor Responders? [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial on DHEA for IVF outcomes in poor responders has been suspended, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHEA (dehydroepiandrosterone)

Snippet

Sponsor: Homerton University Hospital NHS Foundation Trust | Conditions: Infertility, Female, Poor Response to Ovulation Induction | Phase 2, Phase 3 | Status: SUSPENDED